International Assets Investment Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$234K Buy
1,518
+14
+0.9% +$2.1K 0.01% 801
2026
Q1
$233K Buy
1,504
+16
+1% +$2.45K 0.02% 738
2025
Q4
$205K Buy
+1,488
New +$195K 0.01% 803
2024
Q4
Sell
-172,825
Closed -$1.5K 1508
2024
Q3
$1.5K Buy
+172,825
New +$19.6M ﹤0.01% 997
2023
Q4
Sell
-2,230
Closed -$224K 811
2023
Q3
$224K Buy
2,230
+158
+8% +$16K 0.03% 460
2023
Q2
$209K Buy
+2,072
New +$207K 0.03% 500
2023
Q1
Sell
-8,695
Closed -$786K 1315
2022
Q4
$786K Buy
+8,695
New +$732K 0.08% 237
2021
Q2
Sell
-1,855
Closed -$175K 1427
2021
Q1
$175K Hold
1,855
0.02% 546
2020
Q4
$175K Sell
1,855
-1,541
-45% -$135K 0.03% 416
2020
Q3
$295K Buy
3,396
+62
+2% +$5.37K 0.07% 240
2020
Q2
$291K Buy
3,334
+883
+36% +$76.2K 0.07% 238
2020
Q1
$202K Buy
+2,451
New +$219K 0.06% 276

Other funds holding NVS

International Assets Investment Management's NVS Position: Q2 2026 in Review

International Assets Investment Management increased its Novartis (NVS) stake by 0.93% in Q2 2026, buying an estimated $2.1K and bringing the position to 1,518 shares worth $234K. The position accounts for 0.01% of the portfolio, ranked #801.

International Assets Investment Management first reported a position in NVS in Q1 2020 and has held it in 12 quarters since. The position peaked at $786K in Q4 2022. 859 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • International Assets Investment Management held 1,518 shares of Novartis worth $234K as of Q2 2026.
  • International Assets Investment Management bought 14 Novartis shares in Q2 2026, an estimated $2.1K.
  • Novartis made up 0.01% of International Assets Investment Management's portfolio in Q2 2026, its #801 holding.
  • International Assets Investment Management first reported a position in Novartis in Q1 2020 and has held it in 12 quarters since.
  • International Assets Investment Management's Novartis position peaked at $786K in Q4 2022.
  • 859 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on International Assets Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.